Isik K. Atagunduz

Ihlas Marmara Evleri - I. Kisim, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study.

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study.

Journal: Frontiers in medicine

Published: March 12, 2026

HIV-associated lymphoproliferative disorders: Single-center experience.

HIV-associated lymphoproliferative disorders: Single-center experience.

Journal: Medicine

Published: November 05, 2025

Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden.

Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden.

Journal: Diagnostics (Basel, Switzerland)

Published: November 03, 2025

The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia.

The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia.

Journal: Journal of clinical medicine

Published: September 17, 2025

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

Journal: Journal of clinical medicine

Published: August 26, 2025

Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literature.

Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literature.

Journal: Current problems in cancer

Published: January 30, 2025

Bortezomib-Based Salvage Followed by Autologous Transplantation in a Patient with HIV-Negative Plasmablastic Lymphoma.

Bortezomib-Based Salvage Followed by Autologous Transplantation in a Patient with HIV-Negative Plasmablastic Lymphoma.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: November 07, 2024

The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia.

The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia.

Journal: Annals of hematology

Published: June 28, 2023

Impact of autologous stem cell transplantation on survival outcomes in patients with peripheral T cell lymphoma.

Impact of autologous stem cell transplantation on survival outcomes in patients with peripheral T cell lymphoma.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: February 12, 2022

Real-life ruxolitinib experience in intermediate-risk myelofibrosis.

Real-life ruxolitinib experience in intermediate-risk myelofibrosis.

Journal: Blood research

Published: May 18, 2021

Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis.

Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis.

Journal: Cancers

Published: August 31, 2020

Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis.

Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: July 16, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026